Optimization of Flow-Cytometry Based Assay for Measuring Neutralizing Antibody Responses against Each of the Four Dengue Virus Serotypes

Optimization of Flow-Cytometry Based Assay for Measuring Neutralizing Antibody Responses against Each of the Four Dengue Virus Serotypes

Dengue is an important public health problem worldwide, with India contributing nearly a third of global dengue disease burden. The measurement of neutralizing antibody responses is critical for understanding dengue pathophysiology, vaccine development and evaluation. Historically, dengue virus neut...

Full description

Bibliographic Details
Main Authors:	Pragati Sharma, Kaustuv Nayak, Elluri Seetharami Reddy, Humaira Farooqi, Kaja Murali-Krishna, Anmol Chandele
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Vaccines
Subjects:	dengue flowcytometry neutralization focus reduction neutralizing tests
Online Access:	https://www.mdpi.com/2076-393X/9/11/1339

Similar Items

Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2
by: Vanessa Shi Li Goh, et al.
Published: (2024-09-01)

Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates
by: Yadya M. Chawla, et al.
Published: (2024-05-01)

Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection
by: Heidi Auerswald, et al.
Published: (2021-09-01)

Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
by: Deanna R. Zhu, et al.
Published: (2023-10-01)

Neutralizing Antibodies after Infection with Dengue 1 Virus
by: Gustavo Kourí, et al.
Published: (2007-02-01)

Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity
by: Subenya Injampa, et al.
Published: (2017-11-01)

Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody
by: Poonsook Keelapang, et al.
Published: (2023-08-01)

Reporter Virus Neutralization Test Evaluation for Dengue and Zika Virus Diagnosis in Flavivirus Endemic Area
by: Jannyce G. C. Nunes, et al.
Published: (2021-07-01)

Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques
by: Tulika Singh, et al.
Published: (2024-03-01)

Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice
by: Ajit Kulkarni, et al.
Published: (2017-03-01)

The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection
by: Maria G. Guzman, et al.
Published: (2010-12-01)

Evaluation of Measuring Radiation-Induced Apoptosis in Human T-Lymphocytes by Flow Cytometry as a Biological Dosimetry System
by: Mohammad Bagher Tavakkoli, et al.
Published: (2014-07-01)

Utility of an In-Vitro Micro-Neutralizing Test in Comparison to a Plaque Reduction Neutralization Test for Dengue Virus, Japanese Encephalitis Virus, and Zika Virus Serology and Drug Screening
by: Kazumi Haga, et al.
Published: (2023-12-01)

Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data
by: Jean Claude Balingit, et al.
Published: (2024-02-01)

A Simple and High-Throughput ELISA-Based Neutralization Assay for the Determination of Anti-Flavivirus Neutralizing Antibodies
by: Jean Claude Balingit, et al.
Published: (2020-06-01)

Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics
by: Natasha D Durham, et al.
Published: (2019-12-01)

Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?
by: Jedhan Ucat Galula, et al.
Published: (2019-10-01)

Cross-Neutralizing Anti-Chikungunya and Anti-Dengue 2 IgG Antibodies from Patients and BALB/c Mice against Dengue and Chikungunya Viruses
by: Araceli Posadas-Mondragón, et al.
Published: (2024-07-01)

Tax Neutrality on International Capital Investments
by: Gizem KAPUCU
Published: (2017-07-01)

Age-specific kinetics of neutralizing antibodies and infection enhancement among ≤1 year-old Indian infants
by: Shweta Chelluboina, et al.
Published: (2025-02-01)

Calculating rabies virus neutralizing antibodies titres by flow cytometry
by: BORDIGNON Juliano, et al.
Published: (2002-01-01)

A GFP Reporter MR766-Based Flow Cytometry Neutralization Test for Rapid Detection of Zika Virus-Neutralizing Antibodies in Serum Specimens
by: Etienne Frumence, et al.
Published: (2019-07-01)

Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response
by: Jan M. Sobczak, et al.
Published: (2024-06-01)

A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface
by: Guntur Fibriansah, et al.
Published: (2014-01-01)

Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
by: Animesh Sarker, et al.
Published: (2023-06-01)

Pichia pastoris-expressed Dengue 3 Envelope-based Virus-like Particles Elicit Predominantly Domain III-Focused High Titer Neutralizing Antibodies
by: Lav eTripathi, et al.
Published: (2015-09-01)

THE NEUTRALITY OF THE REPUBLIC OF BELARUS AS LEGAL PROVISION
by: O. I. Chupris, et al.
Published: (2018-04-01)

Analysis of Immunophenotypic Changes during Ex Vivo Human Erythropoiesis and Its Application in the Study of Normal and Defective Erythropoiesis
by: Shobhita Katiyar, et al.
Published: (2023-05-01)

COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test
by: Himadri Nath, et al.
Published: (2022-09-01)

A rapid immunization strategy with a live attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
by: Yuping eAmbuel, et al.
Published: (2014-06-01)

Net Neutrality and 5G in India: A Policy Delphi Survey
by: Anuradha Mitra, et al.
Published: (2024-10-01)

A New Method to Monitor the Primary Neutral Integrity in Multi-Grounded Neutral Systems
by: Xiangmin Xie, et al.
Published: (2017-03-01)

Erratum on: A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
by: Frontiers eProduction Office
Published: (2014-09-01)

Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
by: Rochanawan Sootichote, et al.
Published: (2023-01-01)

Preparation and application of porcine broadly neutralizing monoclonal antibodies in an immunoassay for efficiently detecting neutralizing antibodies against foot-and-mouth disease virus serotype O
by: Yimei Cao, et al.
Published: (2025-02-01)

Military neutrality of Serbia and co-operation with Russian Federation
by: Gordić Miodrag L., et al.
Published: (2018-01-01)

Feline Immunodeficiency Virus (FIV) Neutralization: A Review
by: Margaret J. Hosie, et al.
Published: (2011-10-01)

A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients
by: Chao Shan, et al.
Published: (2017-03-01)

High explosive unexploded ordnance neutralization - Tallboy air bomb case study
by: Rafał Miętkiewicz
Published: (2022-03-01)

Seroprevalence of dengue virus infection in Pune City in India, 2019: A decadal change
by: Kalichamy Alagarasu, et al.
Published: (2023-11-01)